+351 211 369 829 
Ophiomics- Precision Medicine
Ophiomics is an ISO 13485 and ISO 9001 certified, clinical-stage Medtech company developing cutting-edge diagnostic products and services integrating bioinformatics, artificial intelligence and genomics in support of diagnostic, prognostic, treatment selection and clinical follow-up in oncology.
Vision & Mission
Our vision: To lead the world in cancer diagnostics and transform the future of healthcare.
Our Mission: We are committed to revolutionizing cancer diagnostics worldwide by leveraging the power of AI and genomics to develop a cutting-edge portfolio of technology-driven, cost-effective products with a massive global impact, significantly enhancing health outcomes.
Actionable
We create practical tools to empower clinicians’ decisions at crucial stages in the cancer patient journey, where preventative or curative interventions are possible.
Novel
We leverage the power of genomics and Machine Learning to discover novel biomarkers that address unmet clinical needs.
Integrative
We integrate biomarkers and clinical variables through cutting-edge machine-learning algorithms, creating solutions to support clinicians’ decisions.
Accessible
Our end-products – IVD medical devices – are designed to seamlessly integrate into routine clinical practice, ensuring accessibility and ease of adoption
Collaborative
We value partnerships with clinicians, academia, patients, and companies, to build upon and advance our approaches, seeking improved outcomes for all.
Jose Leal, PhD (CEO)
José Pereira Leal, PhD, is an Innovator, Scientist, Entrepreneur and medtech and precision medicine enthusiast. A bioinformatician with close to 30 years professional experience, having broad and impactful scientific experience at leading Europe, UK and USA institutions, a leader of research infrastructures and a serial entrepreneur in the areas of biodefense, drug development, clinical diagnostic services and medtech. His personal motto is “better life through technology”.
Joana Vaz, PhD (CSO)
Joana Cardoso Vaz, PhD, is a cancer genomics specialist, with extensive experience in collaborating with clinicians, spanning the journey from biomarker discovery to clinical diagnosis. Her credentials include an MSc in Human Genetics from the School of Medicine of the University of Lisbon (Portugal) and a PhD in Biomedical Sciences from the University of Leiden (Netherlands). Her impactful work encompasses diverse areas within cancer genomics for more than 20 years in academia, and she has led the establishment of a pioneering platform for clinical testin in precision oncology, pioneering for example ccfRNA sequencing in the clinical context. Driven by innovation, she strives to apply her technical knowledge to invent new medical products that can enhance and ultimately save the lives of cancer patients.
Ophiomics @ EASL Milan 2024
Ophiomics is present @EASL2024 in Milan. Visit us at Biotech Village BT3 to discover how HepatoPredict will guide your clinical decisions.@Cl
@ Voice Leadership Program
We are very happy to have been selected to participate in the Voice Leadership Program in the Training and Mentorship stream. This is an initiative by
Ophiomics @ ILTS Houston
Just back from three days of intense learning and networking with leaders in liver transplantation from all over the world. We had the opportunity to
Ophiomics at the Esophagus Conference
Discussing the challenges of early and accurate diagnosis of displasia and how biomarkers can be the key to saving more lives.
Headquarters:
Pólo Tecnológico de Lisboa, Rua António Champalimaud, Lote 1 (sala 14), 1600-514 Lisboa
